Why a New Study Dubbed India the ‘Cancer Capital of the World’
A new study has unveiled an alarming picture of declining overall health in India. The report, released by the Indian multinational healthcare group, Apollo Hospitals, found that skyrocketing cases of cancer and other non-communicable diseases across the country have now made it “the cancer capital of the world.” [time-brightcove not-tgx=”true”] Despite reporting more than a million new cases every year, India’s cancer rate has not yet surpassed countries like Denmark, Ireland, and Belgium, which record some of the highest cancer rates in the world. It is also currently lower than the U.S....
Source: TIME: Health - April 10, 2024 Category: Consumer Health News Authors: Astha Rajvanshi Tags: Uncategorized India Source Type: news

Should I Take Supplements to Sleep? What Experts Think
If you want to understand the importance of sleep, ask someone who spent the previous night tossing and turning. Sleep is a vital function: essential for physical recovery, preparing for the next day, even clearing waste material from the brain. Mounting evidence suggests that getting adequate amounts of sleep each night is even more critical than previously believed, responsible for reducing the risk of serious conditions including dementia, obesity, and stroke. [time-brightcove not-tgx=”true”] Yet so many of us struggle to fall and stay asleep, with more than one-third of U.S. adults failing to get the re...
Source: TIME: Health - April 10, 2024 Category: Consumer Health News Authors: Carly Weeks Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news

The Dying Brain; Obesity Drugs and MS; NurOwn Tries Again
(MedPage Today) -- New research about the dying brain suggested the line between consciousness and death may not be distinct. (The Guardian) A single fecal microbiota transplantation induced mild but sustained effects on motor symptoms in early... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - April 9, 2024 Category: Neurology Source Type: news

Managing Obesity: More Than GLP-1s or Bust Managing Obesity: More Than GLP-1s or Bust
Obesity expert Dr Holly Lofton reviews three alternatives to GLP-1s to help patients drop excess weight.Medscape Internal Medicine (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 9, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news

America ’ s Growing Birthweight Crisis
Americans are increasingly at risk of having lower incomes, poorer health, and a worse shot at opportunity even before they are born. More babies are now born with low birthweights than in the last 30 years. This has caused growing inequalities that can persist if not properly addressed. In certain parts of the country, that risk may be ten-times greater. Underweight newborns are at an increased risk of long term health challenges, lower IQ scores, and developmental delays. New data shows that the frequency of this problem is rising with more than 300,000 newborns now experiencing low birthweight. This public hea...
Source: TIME: Health - April 9, 2024 Category: Consumer Health News Authors: Jeremy Ney Tags: Uncategorized freelance Source Type: news

ACC: Semaglutide Beneficial in Obesity-Related Heart Failure, Type 2 Diabetes
TUESDAY, April 9, 2024 -- Semaglutide leads to larger reductions in heart failure-related symptoms and physical limitations among patients with obesity-related heart failure with preserved ejection fraction and type 2 diabetes, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2024 Category: Pharmaceuticals Source Type: news

What Experts Really Think About Diet Soda
Growing up, Olivia Dreizen Howell, 39, “lived on” diet soda. So did her family. At a family reunion in 1996, everyone sported T-shirts with their shared surname in Diet Coke-can font. “We drank Diet Coke, Diet ginger ale, and Diet Sprite like water—there was no difference in our household,” she says. Like many, Howell believed that sugar-free soda was a benign choice. But the latest research casts doubt on that assumption, linking diet drinks to mood disorders, fatty liver development, autoimmune diseases, and cancer, to name a few.  [time-brightcove not-tgx=”true”] Bef...
Source: TIME: Health - April 9, 2024 Category: Consumer Health News Authors: Perri Ormont Blumberg Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news

Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
Altimmune Inc. NASDAQ: ALT is a clinical-stage biotechnology company specializing in treating liver disease and obesity. Their lead drug, Pemvidutide, has garnered much attention as a GLP-1/glucagon dual agonist similar to the weight-loss treatments Mounjaro and Zepbound by Eli Lilly and Co. NYSE:…#altimmuneinc #alt #pemvidutide #glp1 #mounjaro #elilillyandco #lly #ozempicandwegovy #novonordiskasnyse #nvo (Source: Reuters: Health)
Source: Reuters: Health - April 9, 2024 Category: Consumer Health News Source Type: news

Roswell Park Research Debunks Perceived Benefits of Overweight/Obesity in Lung Cancer Patients
Obesity is associated with a higher risk of developing at least 13 types of cancer — and worse outcomes after diagnosis. But lung cancer seems to be an exception: Studies have shown that patients with a high body mass index (BMI) experience a lower risk of disease recurrence and longer... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 8, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news

Medicare Can Cover Anti-Obesity Drugs for Heart Disease -- But at What Cost?
(MedPage Today) -- On March 8, 2024, FDA approved Wegovy (semaglutide) to treat cardiovascular disease risks -- heart attack, stroke, and death -- for obese or overweight adults with a history of cardiovascular disease, making it the first... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - April 8, 2024 Category: Primary Care Source Type: news

How anti-obesity medications can help with surgery
Yale surgeons discuss the potential benefits of taking anti-obesity medications before and sometimes after total joint replacement or bariatric surgery. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 8, 2024 Category: Universities & Medical Training Source Type: news

Actually, It ’ s OK to Slouch
One of the latest and surprising findings in the field of physical therapy is that slouching is not as bad as we think it is. Certain researchers have gone so far as to say that the conventional fear mongering regarding poor posture can actually be more harmful than slouching itself.  Undoing over a century’s worth of public health messaging about the evils of poor posture—let alone the custom of elders telling youngsters to “sit up straight”—will be a monumental task. [time-brightcove not-tgx=”true”] I know because I’ve spent the better part of a decade researching ...
Source: TIME: Health - April 8, 2024 Category: Consumer Health News Authors: Beth Linker Tags: Uncategorized freelance Source Type: news

Prior Anti-Obesity Drug Use Curbs Weight Loss on Semaglutide Prior Anti-Obesity Drug Use Curbs Weight Loss on Semaglutide
Patients who were overweight or obese lost more weight taking semaglutide if they hadn ' t previously taken another anti-obesity medication.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 8, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

Do Adults With Obesity Feel Pain More Intensely? Do Adults With Obesity Feel Pain More Intensely?
Adults with excess weight or obesity reported higher pain levels, emphasizing the need to address obesity in pain management, according to a systematic review and meta-analysis.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 8, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

Gut Bacteria's Influence on Obesity Differs in Men and Women Gut Bacteria's Influence on Obesity Differs in Men and Women
Different bacterial species affect the onset and development of obesity in men vs women.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 8, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news